EconPapers    
Economics at your fingertips  
 

Enhancing Pharmacovigilance from the US Experience: Current Practices and Future Opportunities

Veronique F. Kugener (), Eric S. Freedland (), Kenneth I. Maynard (), Omar Aimer (), Peggy S. Webster (), Maribel Salas () and Maxine Gossell-Williams ()
Additional contact information
Veronique F. Kugener: Takeda Pharmaceuticals International Co.
Eric S. Freedland: Takeda Pharmaceuticals International Co.
Kenneth I. Maynard: Takeda Pharmaceuticals International Co.
Omar Aimer: Brunel Canada
Peggy S. Webster: GlaxoSmithKline
Maribel Salas: University of Pennsylvania
Maxine Gossell-Williams: University of The West Indies

Drug Safety, 2021, vol. 44, issue 8, No 3, 843-852

Abstract: Abstract This review is intended to present perspectives from the US experience in enhancing pharmacovigilance on current practices and future opportunities. Best practices concepts could be applied worldwide through the presentation of how three pillars of pharmacovigilance: (1) medical and scientific excellence, (2) operational and compliance excellence, and (3) knowledge sharing and experts development in the field could serve as a framework for the establishment of an efficient and successful global pharmacovigilance system.

Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-021-01078-8 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:44:y:2021:i:8:d:10.1007_s40264-021-01078-8

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-021-01078-8

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-20
Handle: RePEc:spr:drugsa:v:44:y:2021:i:8:d:10.1007_s40264-021-01078-8